title: Remissions after long-term use of romiplostim for immune thrombocytopenia.
authors: Division of Hematology, Mayo Clinic. USA marshall.ariela@mayo.edu.
authors: Ariela L
authors: AL
authors: Marshall
authors: Center for Hematology, Massachusetts General Hospital, USA.
authors: Roberta
authors: R
authors: Scarpone
authors: Oncology Pharmacy, Princess Alexandra Hospital, Brisbane, Australia.
authors: Melanie
authors: M
authors: De Greef
authors: Division of Cancer Services, Princess Alexandra Hospital, Brisbane, Australia.
authors: Robert
authors: R
authors: Bird
authors: Center for Hematology, Massachusetts General Hospital, USA.
authors: David J
authors: DJ
authors: Kuter
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy* / Q000473:pathology; D011961:Receptors, Fc / Q000627:therapeutic use*; D053628:Receptors, Thrombopoietin / Q000819:agonists; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D012074:Remission Induction; D013926:Thrombopoietin / Q000627:therapeutic use*; D013997:Time Factors; D055815:Young Adult
chemical_list: D011961:Receptors, Fc; D053628:Receptors, Thrombopoietin; D011993:Recombinant Fusion Proteins; C082218:MPL protein, human; D013926:Thrombopoietin; C488777:romiplostim
keywords: immune thrombocytopenic purpura; platelets; romiplostim; thrombopoietin